3Ricbter WO, Donner MG, Scbwandl P. Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: a long-term evalution [J]. Therapeulie Apheresis, 1999,3(3):203～208.
4Bosch T, Lennertz A, Kordes B, et al. Low density lipoprotein hemoperfusion by direct absorption of lipoproteins from whole blood (DALI apheresis) :clinical experience from a single center [J]. Ther Apher, 1999,3(3) :209～213.
5Kannel EB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: new perspective based on the Framingham study[J]. Ann Intern Med, 1979,90:85.
6Moberly JB, Attman PO, Samuelsson O, et al . Alterations in lipoprotein composition in peritoneal dialysis patients[J ]. Perit Dial Int, 2002,22:1.
7Fytili CI, Progia EG, Panagoutsos SA, et al. Lipoprotein abnormalities in hemodialysis and continuous ambulatory peritoneal dialysis patients[J]. Ren Fail, 2002,24(5) :623-630.
5Epperlein MM, Nourooz-Zadeh J, Jayasena SD, et al. Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol, 1998, 9:457.
6Witztum TL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest, 1991, 88:1785.
7Mei Zhon, Yuan Chen, Shang Xi Liu, et al. Oxidative and malondialdehyde modification of low density lipoprotein: a comparative study of binding and degradation by macrophage and endothelial cells. Brit J Biomed Sci, 1998, 55:192.
8Bonomini M, Sirolli V, Settefrati N, et al. Increased erythrocyte phosphatidyl-serine exposure in chronic renal failure. J Am Soc Nephrol,1999, 10:1982.
9Martin-Mateo MC, Canto-Jafiez E, Barrero-Martinez MJ. Oxidative stress and enzyme activity in ambulatory renal patient undergoing continuous peritoneal dialysis. Renal Failure, 1998, 20:117.
10Roob JM, Rabold T, Hayn M, et al. Ex vivo low-density lipoprotein oxidizabiliby and in vivo lipid peroxidation in patients on CAPD. Kidney Int,2001,78: S128.
